Sintx Technologies (SINT) Gross Profit (2013 - 2026)

Sintx Technologies' (SINT) quarterly Gross Profit came in at $144000.0 in Q1 2026, up 17.07% year-on-year from $123000.0 in Q1 2025, and down 23.4% quarter-over-quarter from $188000.0 in Q4 2025.

Sintx Technologies (SINT) Gross Profit (2013 - 2026) Analysis & Trends

Sintx Technologies' Gross Profit history runs 14 years deep, the most recent figure standing at $144000.0 for Q1 2026.

  • On a quarterly basis, Gross Profit rose 17.07% year-over-year to $144000.0 in Q1 2026; TTM through Mar 2026 was $482000.0, a 72.22% decrease from a year earlier, with the FY2025 full-year figure at $461000.0, down 77.79% from the prior year.
  • Gross Profit retreated to $144000.0 in Q1 2026 per SINT's latest filing, from $188000.0 in the prior quarter.
  • Across five years, Gross Profit topped out at $735000.0 in Q4 2022 and bottomed at $49000.0 in Q1 2022.
  • The 5-year median for Gross Profit is $388000.0 (2024), against an average of $342294.1.
  • Across the five-year window, Gross Profit jumped 1737.5% in 2022 and sank 91.02% in 2025, its largest moves.
  • Year by year, Gross Profit stood at $735000.0 in 2022, then plunged by 37.82% to $457000.0 in 2023, then retreated by 15.1% to $388000.0 in 2024, then plunged by 51.55% to $188000.0 in 2025, then decreased by 23.4% to $144000.0 in 2026.
  • Per Business Quant, the three latest SINT Gross Profit figures stand at $144000.0 (Q1 2026), $188000.0 (Q4 2025), and $93000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn -
10 Sintx Technologies 17,274.80 -1.87 Mn 144,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 144,000.00
Mar 31, 2026 144,000.00
Dec 31, 2025 188,000.00
Dec 31, 2025 188,000.00
Sep 30, 2025 93,000.00
Sep 30, 2025 93,000.00
Jun 30, 2025 57,000.00
Jun 30, 2025 57,000.00
Mar 31, 2025 123,000.00
Mar 31, 2025 123,000.00
Dec 31, 2024 388,000.00
Dec 31, 2024 388,000.00
Sep 30, 2024 589,000.00
Sep 30, 2024 589,000.00
Jun 30, 2024 635,000.00
Jun 30, 2024 635,000.00
Mar 31, 2024 464,000.00
Mar 31, 2024 464,000.00
Dec 31, 2023 457,000.00
Dec 31, 2023 457,000.00